Neurosyphilis primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MMJ}}{{AA}} | {{CMG}}{{AE}}{{MMJ}}{{AA}} | ||
==Overview== | ==Overview== | ||
There is no [[vaccine]] available for prevention of [[syphilis]]. However, effective measures for the primary prevention of [[syphilis]] include abstinence from intimate physical contact with an infected person, consistent use of [[Latex condom|latex condoms]], limiting number of sexual partners, avoidance of sharing sex toys, practising safe sex, routine screening in pregnant females, individuals with high risk behaviours, and those residing in highly prevalent areas. In patients with diagnosed [[syphilis]], early treatment with [[penicillin]] can | There is no [[vaccine]] available for prevention of [[syphilis]]. However, effective measures for the primary prevention of [[syphilis]] include abstinence from intimate physical contact with an infected person, consistent use of [[Latex condom|latex condoms]], limiting number of sexual partners, avoidance of sharing sex toys, practising safe sex, routine screening in pregnant females, individuals with high risk behaviours, and those residing in highly prevalent areas. In patients with diagnosed [[syphilis]], early treatment with [[penicillin]] can widely prevent neurosyphilis. | ||
==Primary prevention== | ==Primary prevention== | ||
There is no [[vaccine]] available for prevention of [[syphilis]].<ref name="pmid19805553">{{cite journal |author=Stamm LV |title=Global challenge of atibiotic-resistant Treponema pallidum |journal=[[Antimicrobial Agents and Chemotherapy]] |volume=54 |issue=2 |pages=583–9 |year=2010 |month=February |pmid=19805553 |pmc=2812177 |doi=10.1128/AAC.01095-09 |url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=19805553 |accessdate=2012-02-21}}</ref><ref name="pmid24135571">{{cite journal |vauthors=Cameron CE, Lukehart SA |title=Current status of syphilis vaccine development: need, challenges, prospects |journal=Vaccine |volume=32 |issue=14 |pages=1602–9 |year=2014 |pmid=24135571 |pmc=3951677 |doi=10.1016/j.vaccine.2013.09.053 |url=}}</ref> | There is no [[vaccine]] available for prevention of [[syphilis]].<ref name="pmid19805553">{{cite journal |author=Stamm LV |title=Global challenge of atibiotic-resistant Treponema pallidum |journal=[[Antimicrobial Agents and Chemotherapy]] |volume=54 |issue=2 |pages=583–9 |year=2010 |month=February |pmid=19805553 |pmc=2812177 |doi=10.1128/AAC.01095-09 |url=http://aac.asm.org/cgi/pmidlookup?view=long&pmid=19805553 |accessdate=2012-02-21}}</ref><ref name="pmid24135571">{{cite journal |vauthors=Cameron CE, Lukehart SA |title=Current status of syphilis vaccine development: need, challenges, prospects |journal=Vaccine |volume=32 |issue=14 |pages=1602–9 |year=2014 |pmid=24135571 |pmc=3951677 |doi=10.1016/j.vaccine.2013.09.053 |url=}}</ref> | ||
| Line 14: | Line 14: | ||
*Practicing safe sex | *Practicing safe sex | ||
*Routine screening in pregnant females, individuals with high risk behaviors, and those residing in highly prevalent areas | *Routine screening in pregnant females, individuals with high risk behaviors, and those residing in highly prevalent areas | ||
In patients with diagnosed [[syphilis]], early treatment with [[penicillin]] can | In patients with diagnosed [[syphilis]], early treatment with [[penicillin]] can widely prevent neurosyphilis.<ref name="pmid2037785">{{cite journal| author=Musher DM| title=Syphilis, neurosyphilis, penicillin, and AIDS. | journal=J Infect Dis | year= 1991 | volume= 163 | issue= 6 | pages= 1201-6 | pmid=2037785 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2037785 }} </ref> | ||
==References== | ==References== | ||
Revision as of 18:05, 19 March 2018
|
Tabes Dorsalis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neurosyphilis primary prevention On the Web |
|
American Roentgen Ray Society Images of Neurosyphilis primary prevention |
|
Risk calculators and risk factors for Neurosyphilis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]Aysha Anwar, M.B.B.S[3]
Overview
There is no vaccine available for prevention of syphilis. However, effective measures for the primary prevention of syphilis include abstinence from intimate physical contact with an infected person, consistent use of latex condoms, limiting number of sexual partners, avoidance of sharing sex toys, practising safe sex, routine screening in pregnant females, individuals with high risk behaviours, and those residing in highly prevalent areas. In patients with diagnosed syphilis, early treatment with penicillin can widely prevent neurosyphilis.
Primary prevention
There is no vaccine available for prevention of syphilis.[1][2]
Effective measures for the primary prevention of syphilis include:[1][2][3]
- Abstinence from intimate physical contact with an infected person
- Consistent use of latex condoms
- Limiting number of sexual partners
- Avoid sharing sex toys
- Practicing safe sex
- Routine screening in pregnant females, individuals with high risk behaviors, and those residing in highly prevalent areas
In patients with diagnosed syphilis, early treatment with penicillin can widely prevent neurosyphilis.[4]
References
- ↑ 1.0 1.1 Stamm LV (2010). "Global challenge of atibiotic-resistant Treponema pallidum". Antimicrobial Agents and Chemotherapy. 54 (2): 583–9. doi:10.1128/AAC.01095-09. PMC 2812177. PMID 19805553. Retrieved 2012-02-21. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Cameron CE, Lukehart SA (2014). "Current status of syphilis vaccine development: need, challenges, prospects". Vaccine. 32 (14): 1602–9. doi:10.1016/j.vaccine.2013.09.053. PMC 3951677. PMID 24135571.
- ↑ http://www.cdc.gov/std/tg2015/syphilis.htm Accessed on September 27, 2016
- ↑ Musher DM (1991). "Syphilis, neurosyphilis, penicillin, and AIDS". J Infect Dis. 163 (6): 1201–6. PMID 2037785.